NL3 - Streamlining the product portfolio / Timelines for phase out of products (ES)
HUMAN - Path to IVDR
- Language:ES
1162 Items are shown
NL3 - Streamlining the product portfolio / Timelines for phase out of products (ES)
HUMAN - Path to IVDR
NL3 - Streamlining the product portfolio / Timelines for phase out of products (FR)
HUMAN - Path to IVDR
NL4 - Phase-out of selected products in Rapid Test, ELISA and Urinalysis (EN)
HUMAN - Path to IVDR
NL4 - Phase-out of selected products in Rapid Test, ELISA and Urinalysis (ES)
HUMAN - Path to IVDR
NL4 - Phase-out of selected products in Rapid Test, ELISA and Urinalysis (FR)
HUMAN - Path to IVDR
NL5 - Grace periods and product phase outs (EN)
HUMAN - Path to IVDR
NL5 - Grace periods and product phase outs (ES)
HUMAN - Path to IVDR
NL5 - Grace periods and product phase outs (FR)
HUMAN - Path to IVDR
Webinar - Market impact of the transition to IVDR
HUMAN - Path to IVDR
Fact Sheet IMTEC-ANA-LIA-XL (EN)
Marketing Material Autoimmune DX